Estrogen-progestin therapy reduces hip fracture

In the Women's Health Initiative, combined estrogen-progestin replacement therapy was associated with significant reduction in hip fracture (five fewer hip fractures per 10,000 person-years; HR 0.7, unadjusted 95% CI 0.4-1.0).

HR: hazard ratio.

Data from: Rossouw JE, Anderson GL, Prentice RL, et al. Risks and benefits of estrogen and progestin in healthy postmenopausal women: principal results from the Women's Health Initiative randomized controlled trial. JAMA 2002; 288:321.

Graphic 55425 Version 4.0

آیا می خواهید مدیلیب را به صفحه اصلی خود اضافه کنید؟

خرید پکیج

Estrogen-progestin therapy reduces hip fracture